dusigitumab human monoclonal antibody designed treatment cancer binds developed medimmune acquired astrazeneca using xenomouse technology licensed development monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikidusigitumab